Ultra Clear Treatment

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Ultra Clear Treatment
Generic name: SALICYLIC ACID
Manufacturer: ULTRACEUTICALS PTY LIMITED
Product type: HUMAN OTC DRUG
SPL set ID: 99b18387-4ab9-4975-e053-2995a90ad6c4
SPL ID: 40954e8b-253c-052d-e063-6294a90ad812
Version: 7
Effective date: 2025-10-07
Source export date: 2026-09-24
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-24/4008330ac0b28271aeb1d4c1a13f62d855c43161c477630f8f4b65c49a7c51ed/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: 06858c06eb1cc3ec877527687035c43ee5d12c4c0df038a164bf6d5d4ba5dd73
Import run: 20260925T050722Z
Imported at: 2026-09-25 05:57:30

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Ultra Clear Treatment	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		ULTRACEUTICALS PTY LIMITED	openfda.manufacturer_name
ndc	package	10028-051-01	openfda.package_ndc
ndc	package	10028-051-02	openfda.package_ndc
ndc	product	10028-051	openfda.product_ndc
ndc11	package	10028005102	derived:openfda.package_ndc
ndc11	package	10028005101	derived:openfda.package_ndc
rxcui		103568	openfda.rxcui
spl id		40954e8b-253c-052d-e063-6294a90ad812	id
spl set id		99b18387-4ab9-4975-e053-2995a90ad6c4	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. When using this product Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water to remove.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.